Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors [3]

QJM: An International Journal of Medicine

Volumn 99, Issue 3, 2006, Pages 197-198

  Karagiannis, A ^a   Pyrpasopoulou, A ^a   Tziomalos, K ^a   Florentin, M ^a   Athyros, V ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TRANDOLAPRIL;

ABSENCE OF SIDE EFFECTS; ADULT; AIRWAY OBSTRUCTION; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CASE REPORT; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; EMERGENCY SURGERY; HUMAN; HYPERTENSION; LETTER; MALE; PRIORITY JOURNAL; TRACHEOSTOMY;

EID: 33645279241     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl022     Document Type: Letter

References (5)

1. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18:171-88.
2. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24:599-606.
3. Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: An underdiagnosed complication of ACE inhibitors? Mayo Clin Proc 2000; 75:1201-4.
4. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347:621-2.
5. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 1998; 351:1693-7.